CrunchBase is hiring! Check out our open positions →

General Information
edit

Offices
edit

M.P. Misgav, ISR

Misgav Venture Accelerator
M.P. Misgav, 20174, ISR

CEO

TOTAL	$2.8M
FUNDING TOTAL	$2.8M
Series B, 8/10 Aurum Ventures Evergreen Venture Partners Trendlines Group	$2.8M

Nephera (Israeli) a development-stage medical device company focused on kidney function in CHF patients.

Nephera received $2.8M in Series B funding. (8/18/10)

Posted 8/18/10 at 5:58pm via onbiovc.com
Nephera added Gill Bar-Yoseph as CEO.

Posted 8/18/10 at 5:58pm

Edit This Page
Last Edited 8/18/10